Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fatigue × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 98 Carcinoma, Intraductal, Noninfiltrating 5 Neoplasms 4 Breast Carcinoma In Situ 4 Neoplasm Metastasis 3 Carcinoma, Ductal, Breast 3 Inflammatory Breast Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Breast Cancer Female 2 Sleep Wake Disorders 1 Quality of Life 1 Pulmonary Fibrosis 1 Prostatic Neoplasms 1 Primary Breast Cancer 1 Paget's Disease, Mammary 1 Obesity 1 Neoplasm Recurrence, Local 1 Liver Neoplasms 1 Infertility 1 Fatigue 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Breast Cancer Subjects 1 Bone Density 1 Advanced Metastatic Breast Cancer 1

Interventions

Methylphenidate 7 Modafinil 4 Therapeutics 3 Acupuncture Therapy 3 Surveys and Questionnaires 2 Radiotherapy 2 Exercise 2 Counseling 2 testosterone enanthate 1 testosterone 17 beta-cypionate 1 exemestane 1 Valeriana extract 1 Triptorelin Pamoate 1 Testosterone 1 Taxes 1 Tamoxifen 1 Sugars 1 Relaxation Therapy 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Psychiatric Rehabilitation 1 Paclitaxel 1 Mental Status and Dementia Tests 1 Materia Medica 1 Infliximab 1 Hypericum extract LI 160 1 Gonadotropin-Releasing Hormone 1 Escitalopram 1 Epoetin Alfa 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡